africa.businessinsider.com·1 min read·medium
Bank of America spends more than $250 million on GLP-1s
✦AI Summary
Bank of America CEO Brian Moynihan announced that the company has invested over $250 million in GLP-1 weight-loss drugs for its employees. The investment is framed as a benefit to improve employee health and well-being.
CEO Brian Moynihan said that the more than $250 million is a worthwhile investment in benefits for his more than 210,000 employees. "We see a great impact on employees," he told CNBC on Wednesday at the Aspen Economic Strategy Group annual meeting, n... [1427 chars]
businesshealtheconomy
✦
Get the full story
Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.
Create free accountAlready have an account? Sign in